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Giant cell myocarditis (GCM) is a rare and frequently fataldisorder of  unknown origin that is defined
histopathologically as diffuse myocardial necrosis with
multinucleated giant cells in the absence of  sarcoid-like
granulomas.1,2 Cardiac transplantation is the treatment of
choice though the disease is known to recur in the donor
heart.2  Occurrence of  atypical mycobacterial infection in
a cardiac transplant recipient is rare. We present a fatal case
of  atypical mycobacterial infection in a cardiac transplant
recipient who underwent heart transplantation for GCM.
Case Report
This 37-year-old female was clinically diagnosed as dilated
cardiomyopathy. Pre-transplant endomyocardial biopsy
revealed non specific features, e.g. mild focal thickening of
the endocardium, myocyte hypertrophy with nucleomegaly
and sarcoplasmic degenerative changes. There was no
myocarditis in the material examined. The patient
underwent orthotopic cardiac transplantation for
intractable cardiac failure. In the postoperative period, the
patient was on immunosuppressive therapy with
cyclosporin, azathioprine and prednisolone. Four
endomyocardial biopsies were taken on days 10, 20, 30 and
60 following transplantation. The first two biopsies revealed
acute rejection of  grade IA (ISHLT). The third biopsy showed
focal ischemic changes while the fourth one showed
interstitial fibrosis and myocyte hypertrophy. The patient
expired on day 100 following transplantation. Postmortem
biopsies from the heart and left lung were taken for
pathological examination.
Pathology:
The native heart: The heart weighed 235 g. Due to the
operative technique, parts of  both the atria and outflow
tracts of  the ventricles were not included in the specimen.
On external examination, the pericardial surface showed a
few small 0.1–0.2 cm grey-white necrotic areas. On opening
the heart, part of  the right atrium included in the specimen
and the tricuspid valve were normal. The right ventricular
cavity had focal endocardial thickening which was
especially prominent over the septal wall. The inflow tract
of  the right ventricle just beneath the tricuspid valve had a
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Brief  Report
Fig. 1. Photomicrograph from the explanted native heart showing necrosis,
lymphohistiocytic infiltrate and giant cells. (H&E×180)
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thrombus, 0.5 cm in diameter. The left atrium and the mitral
valve were normal. The left ventricular cavity was dilated
and showed diffuse endocardial thickening. The ventricular
myocardium had multiple small grey-white areas 0.1–0.2
cm in diameter. Segments of  the epicardial coronary arteries
included in the specimen were normal.
On light microscopic examination, multiple sections
from all the chambers showed large areas of  myonecrosis
and lymphohistiocytic infiltrate with numerous giant cells
(Fig. 1). There was endocardial thickening, widespread
myocyte degeneration and focal replacement fibrosis. No
definite epithelioid cell granuloma was noted. Periodic acid
Schiff  and silver methenamine stains for fungus did not
demonstrate any fungal profile. Ziehl–Neelsen and
auramine–rhodamine stains for acid-fast bacili were
negative. The coronary arteries were histologically normal.
In view of  the presence of  numerous giant cells with
myonecrosis in the absence of  distinct sarcoid-like
granulomas, the diagnosis of  giant cell myocarditis was
considered.
Postmortem biopsy specimens: Postmortem biopsy samples
included tissues from the donor heart and the left lung of
the patient. On light microscopic evaluation, the
endocardium was normal. The myocardium revealed non-
specific changes like myofibre hypertrophy and focal
interstitial edema. The pericardium had multiple discrete
necrotizing granulomas showing central necrosis with a few
epithelioid and giant cells. Sections from the lung showed
similar epithelioid cell granulomas (Fig. 2). Ziehl–Neelsen
stain for acid-fast bacilli demonstrated numerous acid-fast
Myobacterium tuberculosis-like organisms both in the
pericardial and pulmonary granulomas. No fungal profile
or inclusion of  cytomegalovirus infection was identified in
the specimen examined. A diagnosis of  tuberculosis
involving the pericardium and lung was suggested.
Subseqently samples from the explanted native heart (on
which the diagnosis of  GCM was earlier made) and
postmortem biopsies from the heart and lung (histologically
diagnosed as tubercular) were subjected to polymerase
chain reaction (PCR) analysis for the detection of
Mycobacteria in general and M. tuberculosis in particular.
Polymerase chain reaction:
Analysis of  the native heart and postmortem samples: Samples
for PCR were retrieved in the form of  scrapings of  paraffin-
embedded tissue from paraffin blocks and transferred to
1.5 ml polypropylene tubes (Axygen Inc.). The samples were
deparaffinized by extraction with xylene. Residual xylene
was removed by extraction with 100% ethanol, tissue pellets
were dried using acetone and DNA was extracted using 10%
chelex 100.3 Polymerase chain reaction was performed with
the supernatant as follows:
(1) 23 S rDNA PCR assay specific for genus4 Mycobacterium
was done. An amplification product of  174 bps was seen
as expected in the postmortem lung (Fig. 3a) and donor
Fig. 3a. Amplification of  mycobacterial DNA from paraffin-embedded lung
tissue. Amplification reaction products were electrophoresed and visualized by
ethidium bromide staining. Lane M, molecular weight marker; lanes 1 and 2,
DNA from postmortem lung tissue (undiluted and 1:10 dilution, respectively);
lane 3, DNA-negative control; lane 4, M. tuberculosis DNA-positive control;
lane 5, M. tuberculosis DNA-positive control; lanes 6 and 7, DNA-negative
control.
Fig. 3b. Amplification of  mycobacterial DNA from paraffin-embedded heart
tissue. Amplification reaction products were electrophoresed and visualized by
ethidium bromide staining. Lane M, molecular weight marker; lane 1, DNA
isolated from implanted donor heart tissue (postmortem); lane 2, DNA isolated
from explanted native heart; lane 3, M. tuberculosis DNA-positive control;
lane 4, DNA negative-control; lane 5, DNA isolated from implanted donor heart;
lane 6, M. tuberculosis DNA-positive control; lane 7, DNA-negative control.
Fig. 2. Photomicrograph from the lung showing epithelioid cell granuloma with
Langhan's giant cells. (H&E×180)
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heart (Fig. 3b) samples, indicating the presence of  an
organism belonging to the genus Mycobacterium. PCR
failed to amplify 23 S rDNA sequences from the
explanted native heart (Fig. 3b) and thereby, the
possibility of  tuberculosis in the native heart could be
ruled out.
(2) DevR-based PCR assay was not performed in the
explanted heart tissue as the 23 S rDNA-based genus-
specific PCR assay failed to amplify mycobacterial DNA
(Fig. 3b). Following step 1, devR-based PCR was
performed in the postmortem samples from the lung and
donor heart. This assay generates a 513 bps DNA
product specific for M. tuberculosis5 which was negative
in these samples (Figs 3a and 3b). The positivity of
23 S rDNA assay and a negative M. tuberculosis complex-
specific assay suggested the presence of  nontubercular
Mycobacteria (atypical Mycobacteria) in the postmortem
samples of  the heart and lung. The causative
mycobacterial species could not be identified further due
to the nonavailability of  species-specific PCR for assays
of  nontubercular Mycobacteria in our PCR laboratory.
Discussion
Cardiac transplantation is an accepted therapeutic modality
in patients with intractable heart disease. GCM is a rare
disorder characterized histologically by the presence of
diffuse inflammatory infiltrates with multinucleated giant
cells in the absence of  sarcoid-like granulomas. Cardiac
transplantation is a recommended therapeutic procedure
in this condition as the disease is otherwise fatal.2,6
Histological examination of  the explanted native heart in
the present case revealed myocardial necrosis with
lymphohistiocytic infiltrate and giant cells. There was no
obvious granulomatous reaction or presence of  acid-fast
bacilli and thus the diagnosis of  GCM was made.
In the post-transplant period, the patient underwent
episodes of  acute rejection and finally succumbed to
disseminated atypical mycobacterial infection involving
the heart and lungs. While examining the pathological
material from transplant recipients, the possibility of
infection should always be considered as these patients are
immunosuppressed. The two most common infections
which can be identified and diagnosed on endomyocardial
biopsy are cytomegalovirus infection and toxoplasmosis.7
Though tuberculosis has occasionally been described in
cardiac transplant recipients,8,9 the occurrence of  atypical
mycobacterial infection in such patients is distinctly rare.10
The incidence of  tuberculosis among patients undergoing
antirejection therapy is considerably higher than that in the
102 Ray et al. Fatal Atypical Mycobacterial Infection Indian Heart J 2001; 53: 100–103
general population and heart transplant recipients have
been found to carry the highest risk of  tuberculosis.9
Though infections due to nontubercular Mycobacteria in
solid organ transplant recipients are infrequent, they may
be a major cause of  morbidity in such patients. The reported
prevalence of  disease in a heart transplantation program
due to nontubercular Mycobacteria is 0.24%. In the
disseminated form of  the disease, the lungs and
subcutaneous tissue are commonly involved. Intestinal
involvement has rarely been reported in the literature.11 Our
patient is unique as she had a fatal outcome due to atypical
mycobacterial infection involving the lungs and heart
within 100 days of  transplantation. Other organs could not
be examined as an autopsy was not conducted on the
patient.
A high degree of  clinical suspicion of  tubercular
infection is required in cardiac transplant recipients and the
diagnosis needs to be confirmed by histological examination
and/or cultures. Postmortem specimens from the heart and
lung in the present case revealed multiple small necrotizing
granulomas. Ziehl–Neelsen stain demonstrated numerous
acid-fast bacilli and a provisional diagnosis of  tuberculosis
was of fered. The final diagnosis of  nontubercular
mycobacterial infection could only be made following PCR
analysis of  tissues retrieved from the paraffin block as the
genus-specific PCR product was amplified without
amplification of  M. tuberculosis DNA. Polymerase chain
reaction has revolutionized the entire spectrum of
molecular biology as it can offer rapid definitive diagnosis
of  an infective organism including its species specification
and antibiotic resistance profile. Retrieval of  tissue from
paraffin-embedded material and subsequent PCR analysis
can provide an accurate etiological diagnosis even when the
culture report is not available to the pathologist, as in the
present case. While examining the postmortem specimens,
we had a re-look at the original diagnosis of  GCM made on
the explanted native heart. The possibility of  undiagnosed
mycobacterial infection with widespread necrosis and giant
cell reaction could be ruled out due to the absence of
granulomas, negative Ziehl–Neelsen and auramine–
rhodamine staining and non-amplification of  genus-specific
PCR product on retrospective PCR analysis. Thus, heart
transplantation should be considered an unheralded risk
factor for mycobacterial infection, particularly in countries
such as India where the disease is prevalent.
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